Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mihail Slotvitsky"'
Autor:
Aygul Nizamieva, Sheida Frolova, Mihail Slotvitsky, Sandaara Kovalenko, Valeriya Tsvelaya, Anna Nikitina, David Sergeevichev, Konstantin Agladze
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 396:513-524
Botulinum toxin A is a well-known neurotransmitter inhibitor with a wide range of applications in modern medicine. Recently, botulinum toxin A preparations have been used in clinical trials to suppress cardiac arrhythmias, especially in the postopera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1dc23ca277477274157302b2fde82ea
https://doi.org/10.1007/s00210-022-02332-1
https://doi.org/10.1007/s00210-022-02332-1
Autor:
Veronika O. Abrasheva, Sandaara G. Kovalenko, Mihail Slotvitsky, Serafima А. Scherbina, Aleria A. Aitova, Sheida Frolova, Valeria Tsvelaya, Roman A. Syunyaev
Voltage-gated sodium channels are crucial to action potential propagation in excitable tissues. Because of the high amplitude and rapid activation of the sodium current, voltage-clamp measurements are very challenging and are usually performed at roo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204c360190593bcad64b3c28e8bba716
Autor:
Aygul Nizamieva, Sheida Frolova, Mihail Slotvitsky, Sandaara Kovalenko, Valeria Tsvelaya, Anna Nikitina, David Sergeevichev, Konstantin Agladze
Botulinum toxin A is well known as a neurotransmitter inhibitor with a wide range of applications in modern medicine. In recent years, botulinum toxin preparations have begun to be used in clinical trials to suppress cardiac arrhythmias, especially i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7406731e66b7273c600c7d5681cd4a1e
https://doi.org/10.21203/rs.3.rs-1711614/v2
https://doi.org/10.21203/rs.3.rs-1711614/v2
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 168(1)
In vitro screening for potential side effects of drugs on human-induced pluripotent stem-cell-derived cardiomyocytes (hiPSC-CMs) is a cutting-edge technology in pharmaceutical industry. International groups are currently considering using iPSC-CM as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e62ce08fcb105e93c788af1b5291f4
https://pubmed.ncbi.nlm.nih.gov/30388253
https://pubmed.ncbi.nlm.nih.gov/30388253